New England Journal of Medicine · 1987 · 301 citations · 12 references
MedicineGeneticsMolecular GeneticsCardiovascular GeneticsHuman GeneticsMedical GeneticsCardiovascular GenomicsFamilial HypercholesterolemiaGenetic DisordersGenetic RiskLipid Disorder GeneticsLipid DisordersDeletion AnalysisFounder Effect AnalysisGenomic Dna AnalysisHeterozygous Familial HypercholesterolemiaHomozygous DeletionHomozygous Familial HypercholesterolemiaHuman OriginsLow-density Lipoprotein Receptor Genetics
We found a large deletion (more than 10 kilobases) in the gene for the low-density-lipoprotein receptor in 63 percent of French Canadians with heterozygous familial hypercholesterolemia. The deletion also occurred in homozygous form in four of seven French Canadian homozygotes. The deletion removes the promoter and first exon of the gene, and it abolishes the production of messenger RNA for the low-density-lipoprotein receptor. The high frequency of this mutation is presumably related to a founder effect among the 8000 ancestors of present-day French Canadians, who have had relatively little cross-breeding with groups of other national origins. This deletion has not been observed in any other ethnic group. It can be detected by analysis of genomic DNA from blood leukocytes, thus allowing direct diagnosis of familial hypercholesterolemia in a majority of affected French Canadians.
12
George M. Church, W Gilbert · Proceedings of the National Academy of Sciences · 1984 · 8.2K citations · Full text
Mark A. Lehrman, Wolfgang J. Schneider, Michael S. Brown et al. · Journal of Biological Chemistry · 1987 · 281 citations · Full text
Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots
Hagop Youssoufian, Haig H. Kazazian, Deborah G. Phillips et al. · Nature · 1986 · 266 citations